
Fortis Healthcare Limited Announces 30th Annual General Meeting and Releases FY 2025-26 Annual Report
Fortis Healthcare Limited has announced the scheduled date for its 30th Annual General Meeting (AGM), which will be held on Tuesday, August 11, 2026, at 12:00 PM (IST). The meeting will be conducted through Video Conferencing (VC) and Other Audio-Visual Means (OAVM).The company established Friday, July 3, 2026, as the cut-off date to determine shareholder eligibility for receiving the AGM notice and the Annual Report for the financial year 2025-26. The Annual Report, along with other statutory reports including the Business Responsibility and Sustainability Report (BRSR), has been made available on the company website.
AGM and Voting Schedule
The company is providing a remote e-voting facility for its members. The schedule of events related to the AGM is detailed in the table below:| Event | Day and Date | Time |
|---|---|---|
| Record date for payment of dividend | Friday, July 24, 2026 | Not Applicable |
| Cut-off date to determine eligibility to cast votes | Tuesday, August 04, 2026 | Not Applicable |
| Commencement of e-Voting | Thursday, August 06, 2026 | 09:00 AM (IST) |
| End of e-Voting | Monday, August 10, 2026 | 05:00 PM (IST) |
| Annual General Meeting | Tuesday, August 11, 2026 | 12:00 PM (IST) |
Business Responsibility and Sustainability Highlights
In its FY 2025-26 report, Fortis Healthcare highlighted significant progress in Environmental, Social, and Governance (ESG) metrics. The company saw an improvement in its ESG rating from 58 in FY 2023-24 to 68 in FY 2024-25, with notable growth in the environmental domain.Environmental Stewardship:
The company reported a 3.68% reduction in per-occupied-bed energy consumption and achieved a 13% improvement in energy intensity over the last three years. Furthermore, it reduced per-occupied-bed carbon emissions by 8.7% year-on-year, resulting in a net decrease of 4,435 metric tons of CO2 on a consolidated basis. Regarding water resilience, the company recycled 2.75 lakh kiloliters of STP-treated water for horticulture, flushing, and cooling towers.
Social Impact and Human Capital:
Fortis reported a significant improvement in employee skill upgradation training, rising from 81% in FY 2024-25 to 90% in FY 2025-26. The company also noted a decrease in the overall employee attrition rate to 27% in FY 2025-26, down from 36% in FY 2021-22.
Clinical and Patient Metrics:
The report highlights improvements in patient safety metrics:
- CAUTI rates: 0.16 (vs. 0.23 in FY 2023-24) per thousand patient days.
- CLABSI rates: 0.59 (vs. 0.99 in FY 2023-24) per thousand patient days.
- IPD Net Promoter Score (NPS): 73.89% (from 70.02% in FY 2024-25).
- OPD Net Promoter Score (NPS): 72.41% (from 67.32% in FY 2024-25).
Operational and Financial Overview
Fortis Healthcare Limited operates a national presence serving around 7 states. The company maintains 27 offices across India.Financial and Corporate Details:
- Paid-up Capital: Rs. 7,549,581,480
- Turnover (Hospital Activities): 100%
- Net Worth: INR 101,685,040,000
- Reporting Boundary: Consolidated basis excluding Agilus Diagnostics Limited.
Employee Workforce Highlights:
The company employs a total of 29,616 individuals as of the end of FY 2025-26.
| Category | Total Employees | Male | Female |
|---|---|---|---|
| Permanent | 14,649 | 6,647 (45.38%) | 8,002 (54.62%) |
| Other than Permanent | 14,967 | 8,726 (58.30%) | 6,241 (41.70%) |
| Total | 29,616 | 15,373 (51.91%) | 14,243 (48.09%) |
The company also reported that it maintained zero patient data breach incidents for three consecutive years.
FORTIS Stock Price Movement
Fortis Healthcare Limited shares today slipped by 1.15% to settle at ₹952.45. The stock saw a total traded volume of 604,717 shares as it retreated from its intraday high of ₹964.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.